Cite
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.
MLA
Classe, Jean-Marc, et al. “Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.” Anticancer Research, vol. 35, no. 9, Sept. 2015, pp. 4997–5005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26254399&authtype=sso&custid=ns315887.
APA
Classe, J.-M., Glehen, O., Decullier, E., Bereder, J. M., Msika, S., Lorimier, G., Abboud, K., Meeus, P., Ferron, G., Quenet, F., Marchal, F., Gouy, S., Pomel, C., Pocard, M., Guyon, F., & Bakrin, N. (2015). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer. Anticancer Research, 35(9), 4997–5005.
Chicago
Classe, Jean-Marc, Olivier Glehen, Evelyne Decullier, Jean Marc Bereder, Simon Msika, Gérard Lorimier, Karine Abboud, et al. 2015. “Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.” Anticancer Research 35 (9): 4997–5005. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=26254399&authtype=sso&custid=ns315887.